Banner - NPPA Connect

|Videos|April 7, 2023

Considerations in Treatment Selection for BCC

Author(s)Laura Ferris, MD, PhD, Andrew Weinstein, MD, FAAD

Experts in dermatology comment on their considerations relating to treatment selection in their patients with basal cell carcinoma, highlighting the impact of cemipulab in this space.

Episodes in this series

EP. 1 Basal Cell Carcinoma Management Challenges

EP. 1 Basal Cell Carcinoma Management Challenges

EP. 2 Role of Multidisciplinary Care and Early BCC Identification

EP. 2 Role of Multidisciplinary Care and Early BCC Identification

EP. 3 Expert Perspectives on the Role of Interdisciplinary Care in BCC

EP. 3 Expert Perspectives on the Role of Interdisciplinary Care in BCC

EP. 4 Considerations in Treatment Selection for BCC

EP. 4 Considerations in Treatment Selection for BCC

EP. 5 Expert Perspectives in BCC Management

EP. 5 Expert Perspectives in BCC Management

EP. 6 Advances in Locally Advanced BCC Management

EP. 6 Advances in Locally Advanced BCC Management

EP. 7 Clinical Utilization of Cemiplimab and Future Directions

EP. 7 Clinical Utilization of Cemiplimab and Future Directions

EP. 8 Frontline Forum Part 1: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 8 Frontline Forum Part 1: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 9 Frontline Forum Part 2: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 9 Frontline Forum Part 2: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 10 Frontline Forum Part 3: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 10 Frontline Forum Part 3: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 11 Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 11 Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell Carcinoma

EP. 12 Addressing the Challenges and Options to Treat Basal Cell Carcinoma

EP. 12 Addressing the Challenges and Options to Treat Basal Cell Carcinoma

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Immune-Based Strategies Aim to Advance Skin Cancer Prevention

By Shawn Demehri, MD, PhD,Shannon Heaning, Content Associate

August 30th 2026

Topical Immunotherapy Combo Aims to Prevent Skin Cancer in High-Risk Patients

By Shawn Demehri, MD, PhD,Shannon Heaning, Content Associate

August 29th 2026

Calcipotriene and 5-Fluorouracil Combination Targets Skin Cancer Prevention

By Shawn Demehri, MD, PhD,Shannon Heaning, Content Associate

August 27th 2026

TNF Inhibitors Linked to Increased Skin Cancer Risk in Long-Term Cohort Study

ByShannon Heaning, Content Associate

July 22nd 2026

New Frontiers in CSCC: Experts Weigh Immunotherapy Options and Collaborative Referral Pathways

ByMarie Bosslett, Assistant Editor

July 17th 2026

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

Biologic Therapy Linked to Lower 10-Year MACE Risk Across Racial Groups in Psoriasis

Former CDC Director Robert Redfield Joins Turn Therapeutics as Chief Scientific Officer

Body Weight, Not BMI, Associated With Brodalumab Response Trajectory in Plaque Psoriasis

Journal Digest: September 9, 2026

Ultrapulse CO2 Laser Therapy Shows Promise for Chronic Acne Conglobata Sequelae